Current Drug Targets - Inflammation & Allergy

203 papers and 10.6k indexed citations i.

About

The 203 papers published in Current Drug Targets - Inflammation & Allergy in the last decades have received a total of 10.6k indexed citations. Papers published in Current Drug Targets - Inflammation & Allergy usually cover Immunology (70 papers), Physiology (53 papers) and Molecular Biology (34 papers) specifically the topics of Asthma and respiratory diseases (45 papers), Allergic Rhinitis and Sensitization (15 papers) and Cytokine Signaling Pathways and Interactions (14 papers). The most active scholars publishing in Current Drug Targets - Inflammation & Allergy are Kazuo Kobayashi, Nagatoshi Fujiwara, Luigi Naldi, Mohamed L. Salem, Yoshimichi Okayama, Hannu Kankaanranta, Aleksi Lahti, Eeva Moilanen, Riku Korhonen and Ahmet Gül.

In The Last Decade

Fields of papers published in Current Drug Targets - Inflammation & Allergy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Current Drug Targets - Inflammation & Allergy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Drug Targets - Inflammation & Allergy.

Countries where authors publish in Current Drug Targets - Inflammation & Allergy

Since Specialization
Citations

This map shows the geographic impact of research published in Current Drug Targets - Inflammation & Allergy. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Drug Targets - Inflammation & Allergy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Drug Targets - Inflammation & Allergy more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025